Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
GREENSBORO, N.C.--(BUSINESS WIRE)--Merz North America (an affiliate of the global Merz Pharma Group) announced today that the United States (U.S.) Food and Drug Administration (FDA) has approved Naftin® (naftifine HCl) Gel 2% for the treatment of interdigital-type tinea pedis.
Help employers find you! Check out all the jobs and post your resume.
